×

Bharmour Medical Chemists Call for Regulation of E-Pharmacies

The Medical Chemist Association in Bharmour has taken a stand against e-pharmacies, closing local medical stores and clinics to protest unregulated online drug sales. They argue that such practices threaten public health through the risk of counterfeit medications and fraudulent prescriptions. The association emphasizes the importance of personal consultations that local pharmacies provide, which are absent in online transactions. They are calling on the government to enforce strict regulations to protect small medical businesses and ensure the quality of medicines available to the public. Read on to discover more about their demands and concerns.
 

Medical Chemist Association in Bharmour Protests E-Pharmacy Sales


Mahindra Patial
Bharmour


In response to a nationwide initiative led by the All India Organisation of Chemists and Druggists, the Medical Chemist Association in Bharmour staged a complete shutdown on Wednesday. Medical shops, numerous private clinics, and drug vendors across Bharmour closed their doors to protest against the sale of medications online and the operations of e-pharmacy platforms.


Officials from the association expressed concerns that unregulated online drug sales could significantly jeopardize public health. They raised alarms about the increasing prevalence of fraudulent prescriptions, the inappropriate use of antibiotics, and the distribution of counterfeit medications, all of which could have detrimental effects on patients.


Association members pointed out that local pharmacies offer vital consultations and guidance to patients, a crucial service that is often missing in online transactions where personal interaction between the pharmacist and the patient is lacking. They also noted that large e-pharmacy corporations pose a threat to the livelihoods of small business owners.


During the protest, the Association called on the government to implement stringent regulations governing online drug sales to protect the interests of small medical enterprises. They warned that inaction could lead to significant issues regarding the quality and accessibility of medications for the public in the future.